A phase 3 study demonstrated that ritlecitinib was effective and well tolerated in patients with alopecia areata and ≥ 25% ...

Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced a corporate restructuring to ...

Atopy from food allergies to environmental factors can increase hair loss prevalence among children and adults, according to ...

Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...

Panelists discuss how switching therapies in patients with alopecia areata (AA) is often necessary when initial treatments ...

The risk for alopecia areata is increased among patients with lower serum levels of vitamin D and zinc, but no relationship was observed with copper.

A NEW mum who wanted a new bust after having her baby has lost all of her hair following the operation – including her eyelashes and eyebrows. The silicone implants Czech dental worker ...

Q32 Bio (QTTB) announced a corporate restructuring to focus on the advancement of its bempikibart clinical development program for the ...

Comorbid chronic inflammatory diseases influence the prognosis of alopecia areata, according to study findings.

While there's no conclusive evidence that diet causes alopecia areata, some people say that diet can trigger or worsen it.

The goal is to find a cure for alopecia areata, an autoimmune disease that causes hair loss in distinct round patches.